169 related articles for article (PubMed ID: 26892683)
21. Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors.
Sharma V; Malgulwar PB; Purkait S; Patil V; Pathak P; Agrawal R; Kulshreshtha R; Mallick S; Julka PK; Suri A; Sharma BS; Suri V; Sharma MC; Sarkar C
Carcinogenesis; 2017 Feb; 38(2):152-161. PubMed ID: 27993893
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Int J Clin Exp Pathol; 2014; 7(11):7597-609. PubMed ID: 25550796
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.
Supic G; Kozomara R; Zeljic K; Jovic N; Magic Z
Clin Oral Investig; 2017 Jan; 21(1):173-182. PubMed ID: 26966018
[TBL] [Abstract][Full Text] [Related]
24. DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas.
Amara K; Ziadi S; Hachana M; Soltani N; Korbi S; Trimeche M
Cancer Sci; 2010 Jul; 101(7):1722-30. PubMed ID: 20398054
[TBL] [Abstract][Full Text] [Related]
25. Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1.
Huang C; Liu H; Gong XL; Wu LY; Wen B
Oncol Rep; 2017 Mar; 37(3):1637-1645. PubMed ID: 28098901
[TBL] [Abstract][Full Text] [Related]
26. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
27. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.
So AY; Jung JW; Lee S; Kim HS; Kang KS
PLoS One; 2011 May; 6(5):e19503. PubMed ID: 21572997
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y
Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
[TBL] [Abstract][Full Text] [Related]
30. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis.
Qu Y; Mu G; Wu Y; Dai X; Zhou F; Xu X; Wang Y; Wei F
Am J Clin Pathol; 2010 Nov; 134(5):826-34. PubMed ID: 20959668
[TBL] [Abstract][Full Text] [Related]
32. DNA methyltransferases 3a and 3b are differentially expressed in the early stages of a rat liver carcinogenesis model.
Valencia Antúnez CA; Taja Chayeb L; Rodríguez-Segura MÁ; López Álvarez GS; García-Cuéllar CM; Villa Treviño S
Oncol Rep; 2014 Nov; 32(5):2093-103. PubMed ID: 25190601
[TBL] [Abstract][Full Text] [Related]
33. Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B.
Przybylski M; Kozłowska A; Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2010 Apr; 64(4):254-8. PubMed ID: 19932585
[TBL] [Abstract][Full Text] [Related]
34. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.
Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C
Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.
Melling N; Thomsen E; Tsourlakis MC; Kluth M; Hube-Magg C; Minner S; Koop C; Graefen M; Heinzer H; Wittmer C; Sauter G; Wilczak W; Huland H; Simon R; Schlomm T; Steurer S; Krech T
Carcinogenesis; 2015 Nov; 36(11):1333-40. PubMed ID: 26392259
[TBL] [Abstract][Full Text] [Related]
36. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.
Cao XY; Ma HX; Shang YH; Jin MS; Kong F; Jia ZF; Cao DH; Wang YP; Suo J; Jiang J
World J Gastroenterol; 2014 Jul; 20(25):8201-8. PubMed ID: 25009393
[TBL] [Abstract][Full Text] [Related]
37. Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature.
Xu B; Abourbih S; Sircar K; Kassouf W; Mansure JJ; Aprikian A; Tanguay S; Brimo F
Arch Pathol Lab Med; 2013 Oct; 137(10):1326-36. PubMed ID: 24079759
[TBL] [Abstract][Full Text] [Related]
38. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
39. Association between mRNA levels of DNMT1, DNMT3A, DNMT3B, MBD2 and LINE-1 methylation status in infants with tetralogy of Fallot.
Sheng W; Qian Y; Wang H; Ma X; Zhang P; Chen L; Ma D; Huang G
Int J Mol Med; 2013 Sep; 32(3):694-702. PubMed ID: 23820632
[TBL] [Abstract][Full Text] [Related]
40. Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder.
Hinz S; Kempkensteffen C; Christoph F; Hoffmann M; Krause H; Schrader M; Schostak M; Miller K; Weikert S
J Cancer Res Clin Oncol; 2008 Mar; 134(3):331-6. PubMed ID: 17694325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
